Transient Depletion of Pre-Existing Antibodies for Efficient AAV Gene Delivery Treating MPS IIIA in Mice

被引:0
|
作者
Fu, Haiyan [1 ]
Samowitz, Preston [1 ]
Robinson, Michael [1 ]
Forsberg, John [1 ]
Feng, Richard [1 ]
Nicely, Nathan [1 ]
Bobo, Tierra [1 ]
机构
[1] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC USA
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
270
引用
收藏
页码:130 / 130
页数:1
相关论文
共 50 条
  • [1] Transient depletion of pre-existing antibodies for efficient AAV gene delivery
    Fu, Haiyan
    Samowitz, Preston
    Forsberg, John
    Feng, Richard
    Nicely, Nathan
    Bobo, Tierra
    [J]. MOLECULAR GENETICS AND METABOLISM, 2022, 135 (02) : S44 - S44
  • [2] A Novel Approach for Rapid and Transient Depletion of Pre-Existing Neutralizing Antibodies Against AAV Vectors
    Elmore, Zachary
    Oh, Daniel
    Simon, Katherine
    Fanous, Marco
    Asokan, Aravind
    [J]. MOLECULAR THERAPY, 2020, 28 (04) : 398 - 398
  • [3] Delivery of AAV-hAADC to rats with pre-existing immunity to AAV
    Sanftner, L
    Suzuki, B
    Doroudchi, M
    Feng, L
    McClelland, A
    Forsayeth, J
    Cunningham, J
    [J]. MOLECULAR THERAPY, 2003, 7 (05) : S90 - S90
  • [4] Effective Depletion of Pre-Existing Anti-AAV Antibodies Requires Broad Immune Targeting
    Fu, Haiyan
    Meadows, Aaron S.
    Velazquez, Victoria
    Camboni, Marybeth
    Pineda, Ricardo
    Duncan, F. Jason
    Walker, Christopher M.
    McCarty, Douglas M.
    [J]. MOLECULAR THERAPY, 2016, 24 : S276 - S276
  • [5] Effective Depletion of Pre-existing Anti-AAV Antibodies Requires Broad Immune Targeting
    Velazquez, Victoria M.
    Meadows, Aaron S.
    Pineda, Ricardo J.
    Camboni, Marybeth
    McCarty, Douglas M.
    Fu, Haiyan
    [J]. MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2017, 4 : 159 - 168
  • [6] Impacts of Pre-Existing Antibodies on Transduction Efficiency of Systemic AAV9 Gene Delivery: Potential for Broader Patient Eligibility for AAV Gene Therapy
    Meadows, Aaron S.
    Pineda, Ricardo
    Fu, Haiyan
    [J]. MOLECULAR THERAPY, 2018, 26 (05) : 102 - 103
  • [7] Gene Therapy for MPS VI Is Effective in Cats without Pre-Existing Immunity to AAV8
    Ferla, Rita
    O'Malley, Thomas
    Calcedo, Roberto
    O'Donnell, Patricia
    Wang, Ping
    Cotugno, Gabriella
    Claudiani, Pamela
    Wilson, James M.
    Haskins, Mark
    Auricchio, Alberto
    [J]. MOLECULAR THERAPY, 2013, 21 : S138 - S139
  • [8] Influence of Pre-Existing Neutralizing Antibodies on Gene Expression Following Intramuscular Administration of AAV Vectors
    Greig, Jenny A.
    McMenamin, Deirdre
    Wilson, James M.
    [J]. MOLECULAR THERAPY, 2011, 19 (07) : 1364 - 1365
  • [9] Pre-existing Anti-Adeno-Associated Virus Antibodies as a Challenge in AAV Gene Therapy
    Jeune, Vedell Louis
    Joergensen, Jakob A.
    Hajjar, Roger J.
    Weber, Thomas
    [J]. HUMAN GENE THERAPY METHODS, 2013, 24 (02) : 59 - U89
  • [10] Strategy to detect pre-existing immunity to AAV gene therapy
    Falese, L.
    Sandza, K.
    Yates, B.
    Triffault, S.
    Gangar, S.
    Long, B.
    Tsuruda, L.
    Carter, B.
    Vettermann, C.
    Zoog, S. J.
    Fong, S.
    [J]. GENE THERAPY, 2017, 24 (12) : 768 - 778